Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
Narcan nasal spray — the first Food and Drug Administration-approved nasal spray version of naloxone, a medication that reverses the side effects of an opioid overdose — has been made available at 96 Kroger locations across the state of Kentucky,…
In June, the CDC recommended against using AstraZeneca's nasal flu vaccine, FluMist, citing a lack of evidence regarding the vaccine's efficacy. Now, results from a new Canadian study contradict this decision and point to the vaccine's effectiveness.
Researchers examined the ethical implications surrounding the close-knit relationships physicians and medical device representative develop in the operating room in a new study published in the journal Plos One.
The Food and Drug Administration on Monday launched an updated web-based version of the "Orange Book" — the agency's publication that lists all drug approvals on the basis of safety and efficacy.
Bavarian Nordic, a Danish biotech company, entered into a drug supply agreement with New York-based Bristol-Myers Squibb.
Walgreens recently added secure medication disposal kiosks to 45 stores throughout Illinois, reports the Chicago Tribune.
After experiencing statewide blood shortages this spring, Anchorage-based Blood Bank of Alaska experienced a surplus of donations. Now the bank is shipping extra blood to California, according to the Alaska Dispatch News.
Economic pressures to control the rising cost of medical devices has intensified efforts by providers to make better informed purchasing decisions and elicited demand for better "proof" of product superiority from manufacturers.
Atiq Rehman, M.D., director, Robotic and Minimally Invasive Cardiac Surgery, Our Lady of Lourdes Medical Center; Michael Schlosser, M.D., chief medical officer, HealthTrust; & Eugene S. Schneller, PhD, professor of supply chain management, W.P. Carey Scho
Every year, a secretive board of physicians and a pharmacist decides which drugs will be excluded from Express Scripts coverage for the upcoming year, according to the St. Louis Dispatch.
Indian drugmaker Aurobindo Pharma will open a facility to manufacture 50 million vaccine doses per year to prepare for its commercial launch of vaccine products in 2018, according to Business Standard.